[Rick Lee]

The bad guy's personal ethics aside, he could be doing the world a favor by exposing the true market value of a drug that was so grossly underpriced that no one else wanted to bother with it.

If $750/tablet is reflective of the market, then he will certainly attract competition that now sees making a generic copy as a viable option. That will be good for everyone. If he left the price at $13/tablet and continued to lose money on it, they'd eventually stop making it and then no one would have it. The fact that its patent expired decades ago suggests no one else thinks it's worthwhile to copy at the $13/tablet price point.

Trashing his personal ethics and past financial dealings is for the intellectually lazy, who don't want to bother with economic reality.